List of Tables

Table 1. Antitumor Peptide Drugs Market Size & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Antitumor Peptide Drugs Market Restraints

Table 3. Antitumor Peptide Drugs Market Trends

Table 4. Antitumor Peptide Drugs Industry Policy

Table 5. Global Antitumor Peptide Drugs Revenue by Company, 2020-2025, US$ million

Table 6. Global Antitumor Peptide Drugs Revenue Market Share by Company, 2020-2025

Table 7. Global Antitumor Peptide Drugs Sales Volume by Company, 2020-2025, (kg)

Table 8. Global Antitumor Peptide Drugs Sales Volume by Company, 2020-2025

Table 9. Global Antitumor Peptide Drugs Price by Company, 2020-2025, (US$/g)

Table 10. Global Antitumor Peptide Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Antitumor Peptide Drugs Mergers & Acquisitions, Expansion Plans

Table 12. Global Antitumor Peptide Drugs Manufacturers Product Type

Table 13. China Antitumor Peptide Drugs Revenue by Company, 2020-2025, US$ million

Table 14. China Antitumor Peptide Drugs Revenue Market Share by Company, 2020-2025

Table 15. China Antitumor Peptide Drugs Sales Volume by Company, 2020-2025, (kg)

Table 16. China Antitumor Peptide Drugs Sales Volume Market Share by Company, 2020-2025

Table 17. China Market, Antitumor Peptide Drugs Production, Sales, Import and Export, 2020-2025, (kg)

Table 18. China Market, Antitumor Peptide Drugs Production, Sales, Import and Export, 2020-2031, (kg)

Table 19. China Antitumor Peptide Drugs Import & Export Trends

Table 20. Main Sources of China Antitumor Peptide Drugs Import

Table 21. Export Destination of China Antitumor Peptide Drugs

Table 22. Global Headquarters and Manufacturing Base of Antitumor Peptide Drugs Manufacturers

Table 23. Global Major Manufacturers, Antitumor Peptide Drugs Capacity Expansion and Future Plans

Table 24. Global Antitumor Peptide Drugs Production & Forecast by Region, 2020 VS 2024 VS 2031, (kg)

Table 25. Global Antitumor Peptide Drugs Production by Region, 2020-2025, (kg)

Table 26. Global Antitumor Peptide Drugs Production Forecast by Region, 2026-2031, (kg)

Table 27. Global Key Players of Antitumor Peptide Drugs Upstream (Raw Materials)

Table 28. Global Antitumor Peptide Drugs Typical Customers

Table 29. Antitumor Peptide Drugs Typical Distributors

Table 30. by Type, Global Antitumor Peptide Drugs Revenue & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. by Application, Global Antitumor Peptide Drugs Revenue & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 32. By Region, Global Antitumor Peptide Drugs Market Size, 2020 VS 2024 VS 2031, US$ Million

Table 33. By Region, Global Antitumor Peptide Drugs Revenue, 2020-2031, US$ Million

Table 34. By Region, Global Antitumor Peptide Drugs Revenue, 2026-2031, US$ Million

Table 35. By Region, Global Antitumor Peptide Drugs Sales Volume, 2020-2025, (kg)

Table 36. By Region, Global Antitumor Peptide Drugs Sales Volume, 2020-2031, (kg)

Table 37. By Country, Global Antitumor Peptide Drugs Revenue & CAGR，2020 VS 2024 VS 2031, US$ Million

Table 38. By Country, Global Antitumor Peptide Drugs Revenue, 2020-2025, US$ Million

Table 39. By Country, Global Antitumor Peptide Drugs Revenue, 2026-2031, US$ Million

Table 40. By Country, Global Antitumor Peptide Drugs Revenue Market Share, 2020-2025

Table 41. By Country, Global Antitumor Peptide Drugs Revenue Market Share, 2026-2031

Table 42. By Country, Global Antitumor Peptide Drugs Sales Volume, 2020-2025, (kg)

Table 43. By Country, Global Antitumor Peptide Drugs Sales Volume, 2026-2031, (kg)

Table 44. By Country, Global Antitumor Peptide Drugs Sales Volume Market Share, 2020-2025

Table 45. By Country, Global Antitumor Peptide Drugs Sales Volume Market Share, 2026-2031

Table 46. Ipsen Company Information, Head Office, Market Area, and Industry Position

Table 47. Ipsen Antitumor Peptide Drugs Models, Specifications, and Application

Table 48. Ipsen Antitumor Peptide Drugs Sales Volume (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2020-2025

Table 49. Ipsen Company Profile and Main Business

Table 50. Ipsen Recent Developments

Table 51. Novartis Company Information, Head Office, Market Area, and Industry Position

Table 52. Novartis Antitumor Peptide Drugs Models, Specifications, and Application

Table 53. Novartis Antitumor Peptide Drugs Sales Volume (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2020-2025

Table 54. Novartis Company Profile and Main Business

Table 55. Novartis Recent Developments

Table 56. AstraZeneca Company Information, Head Office, Market Area, and Industry Position

Table 57. AstraZeneca Antitumor Peptide Drugs Models, Specifications, and Application

Table 58. AstraZeneca Antitumor Peptide Drugs Sales Volume (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2020-2025

Table 59. AstraZeneca Company Profile and Main Business

Table 60. AstraZeneca Recent Developments

Table 61. AbbVie Company Information, Head Office, Market Area, and Industry Position

Table 62. AbbVie Antitumor Peptide Drugs Models, Specifications, and Application

Table 63. AbbVie Antitumor Peptide Drugs Sales Volume (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2020-2025

Table 64. AbbVie Company Profile and Main Business

Table 65. AbbVie Recent Developments

Table 66. Ferring Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 67. Ferring Pharmaceuticals Antitumor Peptide Drugs Models, Specifications, and Application

Table 68. Ferring Pharmaceuticals Antitumor Peptide Drugs Sales Volume (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2020-2025

Table 69. Ferring Pharmaceuticals Company Profile and Main Business

Table 70. Ferring Pharmaceuticals Recent Developments

Table 71. Tolmar Company Information, Head Office, Market Area, and Industry Position

Table 72. Tolmar Antitumor Peptide Drugs Models, Specifications, and Application

Table 73. Tolmar Antitumor Peptide Drugs Sales Volume (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2020-2025

Table 74. Tolmar Company Profile and Main Business

Table 75. Tolmar Recent Developments

Table 76. Foresee Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 77. Foresee Pharmaceuticals Antitumor Peptide Drugs Models, Specifications, and Application

Table 78. Foresee Pharmaceuticals Antitumor Peptide Drugs Sales Volume (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2020-2025

Table 79. Foresee Pharmaceuticals Company Profile and Main Business

Table 80. Foresee Pharmaceuticals Recent Developments

List of Figures

Figure 1. Antitumor Peptide Drugs Picture

Figure 2. By Revenue, Global Antitumor Peptide Drugs Market Size and Forecast, 2020-2031, US$ Million

Figure 3. By Sales Volume, Global Antitumor Peptide Drugs Market Size and Forecast, 2020-2031, (kg)

Figure 4. Global Antitumor Peptide Drugs Price Trend, 2020-2031, (US$/g)

Figure 5. By Revenue, China Antitumor Peptide Drugs Market Size and Forecast, 2020-2031, US$ million

Figure 6. By Sales Volume, China Antitumor Peptide Drugs Market Size and Forecast, 2020-2031, (kg)

Figure 7. China Antitumor Peptide Drugs Price Trend, 2020-2031 (US$/g)

Figure 8. By Revenue, China Antitumor Peptide Drugs Share of Global Market, 2020-2031

Figure 9. By Sales Volume, China Antitumor Peptide Drugs Share of Global Market, 2020-2031

Figure 10. Global Antitumor Peptide Drugs Key Participants, Market Share, 2023 VS 2024 VS 2025

Figure 11. Global Antitumor Peptide Drugs Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 12. China Antitumor Peptide Drugs Key Participants, Market Share, 2023 VS 2024 VS 2025

Figure 13. China Antitumor Peptide Drugs Key Participants, Market Share, 2024

Figure 14. China Antitumor Peptide Drugs Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2020-2025

Figure 15. Chinese Local Players, Proportion of Antitumor Peptide Drugs Domestic VS Export, 2024

Figure 16. Global Antitumor Peptide Drugs Capacity, Production and Capacity Utilization, 2020-2031

Figure 17. Global Antitumor Peptide Drugs Capacity Market Share by Region, 2024 VS 2031

Figure 18. Global Antitumor Peptide Drugs Production Market Share & Forecast by Region, 2020-2031

Figure 19. Antitumor Peptide Drugs Industry Chain

Figure 20. Antitumor Peptide Drugs Procurement Model

Figure 21. Antitumor Peptide Drugs Sales Model

Figure 22. Antitumor Peptide Drugs Sales Channels, Direct Sales, and Distribution

Figure 23. Lanreotide

Figure 24. Octreotide

Figure 25. Goserelin

Figure 26. Leuprolide

Figure 27. Degarelix

Figure 28. by Type, Global Antitumor Peptide Drugs Revenue, 2020-2031, US$ Million

Figure 29. by Type, Global Antitumor Peptide Drugs Revenue Market Share, 2020-2031

Figure 30. by Type, Global Antitumor Peptide Drugs Sales Volume, 2020-2031, (kg)

Figure 31. by Type, Global Antitumor Peptide Drugs Sales Volume Market Share, 2020-2031

Figure 32. by Type, Global Antitumor Peptide Drugs Price, 2020-2031, (US$/g)

Figure 33. Hospital

Figure 34. Clinic

Figure 35. Others

Figure 36. by Application, Global Antitumor Peptide Drugs Revenue, 2020-2031, US$ Million

Figure 37. by Application, Global Antitumor Peptide Drugs Revenue Market Share, 2020-2031

Figure 38. by Application, Global Antitumor Peptide Drugs Sales Volume, 2020-2031, (kg)

Figure 39. by Application, Global Antitumor Peptide Drugs Sales Volume Market Share, 2020-2031

Figure 40. by Application, Global Antitumor Peptide Drugs Price, 2020-2031, (US$/g)

Figure 41. By Region, Global Antitumor Peptide Drugs Revenue Market Share, 2020-2031

Figure 42. By Region, Global Antitumor Peptide Drugs Sales Volume Market Share, 2020-2031

Figure 43. North America Antitumor Peptide Drugs Revenue & Forecasts, 2020-2031, US$ Million

Figure 44. By Country, North America Antitumor Peptide Drugs Revenue Market Share, 2024

Figure 45. Europe Antitumor Peptide Drugs Revenue & Forecasts, 2020-2031, US$ Million

Figure 46. By Country, Europe Antitumor Peptide Drugs Revenue Market Share, 2024

Figure 47. Asia Pacific Antitumor Peptide Drugs Revenue & Forecasts, 2020-2031, US$ Million

Figure 48. By Country/Region, Asia Pacific Antitumor Peptide Drugs Revenue Market Share, 2024

Figure 49. South America Antitumor Peptide Drugs Revenue & Forecasts, 2020-2031, US$ Million

Figure 50. By Country, South America Antitumor Peptide Drugs Revenue Market Share, 2024

Figure 51. Middle East & Africa Antitumor Peptide Drugs Revenue & Forecasts, 2020-2031, US$ Million

Figure 52. United States Antitumor Peptide Drugs Sales Volume, 2020-2031, (kg)

Figure 53. By Company, United States Antitumor Peptide Drugs Market Share, 2024

Figure 54. by Type, United States Antitumor Peptide Drugs Sales Volume Market Share, 2024 VS 2031

Figure 55. by Application, United States Antitumor Peptide Drugs Sales Volume Market Share, 2024 VS 2031

Figure 56. Europe Antitumor Peptide Drugs Sales Volume, 2020-2031, (kg)

Figure 57. By Company, Europe Antitumor Peptide Drugs Market Share, 2024

Figure 58. by Type, Europe Antitumor Peptide Drugs Market Size, Share, 2024 VS 2031

Figure 59. by Application, Europe Antitumor Peptide Drugs Market Size, Share, 2024 VS 2031

Figure 60. China Antitumor Peptide Drugs Sales Volume, 2020-2031, (kg)

Figure 61. By Company, China Antitumor Peptide Drugs Market Share, 2024

Figure 62. by Type, China Antitumor Peptide Drugs Market Size, Share, 2024 VS 2031

Figure 63. by Application, China Antitumor Peptide Drugs Market Size, Share, 2024 VS 2031

Figure 64. Japan Antitumor Peptide Drugs Sales Volume, 2020-2031, (kg)

Figure 65. By Company, Japan Antitumor Peptide Drugs Market Share, 2024

Figure 66. by Type, Japan Antitumor Peptide Drugs Market Size, Share, 2024 VS 2031

Figure 67. by Application, Japan Antitumor Peptide Drugs Market Size, Share, 2024 VS 2031

Figure 68. South Korea Antitumor Peptide Drugs Sales Volume, 2020-2031, (kg)

Figure 69. By Company, South Korea Antitumor Peptide Drugs Market Share, 2024

Figure 70. by Type, South Korea Antitumor Peptide Drugs Market Size, Share, 2024 VS 2031

Figure 71. by Application, South Korea Antitumor Peptide Drugs Market Size, Share, 2024 VS 2031

Figure 72. Southeast Asia Antitumor Peptide Drugs Sales Volume, 2020-2031, (kg)

Figure 73. By Company, Southeast Asia Antitumor Peptide Drugs Market Share, 2024

Figure 74. by Type, Southeast Asia Antitumor Peptide Drugs Market Size, Share, 2024 VS 2031

Figure 75. by Application, Southeast Asia Antitumor Peptide Drugs Market Size, Share, 2024 VS 2031

Figure 76. India Antitumor Peptide Drugs Sales Volume, 2020-2031, (kg)

Figure 77. By Company, India Antitumor Peptide Drugs Market Share, 2024

Figure 78. by Type, India Antitumor Peptide Drugs Market Size, Share, 2024 VS 2031

Figure 79. by Application, India Antitumor Peptide Drugs Market Size, Share, 2024 VS 2031

Figure 80. Middle East & Africa Antitumor Peptide Drugs Sales Volume, 2020-2031, (kg)

Figure 81. By Company, Middle East & Africa Antitumor Peptide Drugs Market Share, 2024

Figure 82. by Type, Middle East & Africa Antitumor Peptide Drugs Market Size, Share, 2024 VS 2031

Figure 83. by Application, Middle East & Africa Antitumor Peptide Drugs Market Size, Share, 2024 VS 2031

Figure 84. Research Methodology

Figure 85. Breakdown of Primary Interviews

Figure 86. Bottom-up Approaches

Figure 87. Top-down Approaches